Patent Assignment
Reel/Frame 060622/0317
Assignment of Assignor's Interest
Recorded: 2022-07-26
Pages: 3
Assignor
KADMON PHARMACEUTICALS, LLC
Executed: 2022-07-14
Assignee
CHARTWELL PHARMACEUTICALS LLC
77 BRENNER DRIVE, CONGERS, NEW YORK, 10016
Covered Property
(1)
Large Dose Ribavirin Formulations
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Jun 25, 2013
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030678/0620 →
Security Agreement
Jun 25, 2013
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 030678/0514 →
Release of Security Interest
Aug 31, 2015
From: MACQUARIE US TRADING LLC
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 036461/0825 →
Security Interest
Aug 31, 2015
From: KADMON PHARMACEUTICALS, LLC
To: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
Reel/Frame 036460/0811 →
Security Interest
Sep 2, 2015
From: KADMON PHARMACEUTICALS, LLC
To: MACQUARIE US TRADING LLC
Reel/Frame 036478/0611 →
Change of Name
Feb 3, 2016
From: THREE RIVERS PHARMACEUTICALS, LLC
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 037690/0466 →
Termination of Patent and Trademark Security Agreement
Nov 25, 2019
From: PERCEPTIVE CREDIT OPPORTUNITIES FUND, LP
To: KADMON PHARMACEUTICALS, LLC
Reel/Frame 051106/0789 →